Chemical and explosive business ORI has not recovered from its COVID sell-off although we should note the stock started turning lower back in 2019. Mays half-year results had no major hidden surprises although it did disappoint delivering a 9% drop in revenue and a 25% decline in earnings, this could become a classic case of the worst is behind us. Hence MM feels this is a prime candidate for a recovery play which has been a theme over recent months with a number of underperformers rallying strongly.
MM likes ORI as an aggressive play
Add To Hit List
